1.
Gould SR, Brash AR, Conolly ME. Increased prostaglandin production in ulcerative colitis . Lancet. 1977; ; 2 : :98..
2.
Murakami M, Naraba H, Tanioka T, et al. Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2 . J Biol Chem. 2000; ; 275 : :32783.–32792.
3.
Sharon P, Ligumsky M, Rachmilewitz D, Zor U. Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine . Gastroenterology. 1978; ; 75 : :638.–640.
4.
Rodriguez-Lagunas MJ, Martin-Venegas R, Moreno JJ, Ferrer R. PGE2 promotes Ca2+-mediated epithelial barrier disruption through EP1 and EP4 receptors in Caco-2 cell monolayers . Am J Physiol Cell Physiol. 2010; ; 299 : :C324.–C334.
5.
Ajuebor MN, Singh A, Wallace JL. Cyclooxygenase-2-derived prostaglandin D(2) is an early anti-inflammatory signal in experimental colitis . Am J Physiol Gastrointest Liver Physiol. 2000; ; 279 : :G238.–G244.
6.
Vong L, Ferraz JG, Panaccione R, et al. A pro-resolution mediator, prostaglandin D(2), is specifically up-regulated in individuals in long-term remission from ulcerative colitis . Proc Natl Acad Sci USA. 2010; ; 107 : :12023.–12027.
7.
Zamuner SR, Bak AW, Devchand PR, Wallace JL. Predisposition to colorectal cancer in rats with resolved colitis: role of cyclooxygenase-2-derived prostaglandin d2 . Am J Pathol. 2005; ; 167 : :1293.–1300.
8.
Hokari R, Kurihara C, Nagata N, et al. Increased expression of lipocalin-type-prostaglandin D synthase in ulcerative colitis and exacerbating role in murine colitis . Am J Physiol Gastrointest Liver Physiol. 2011; ; 300 : :G401.–G408.
9.
Smith WL, Urade Y, Jakobsson PJ. Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis . Chem Rev. 2011; ; 111 : :5821.–5865.
10.
Malki S, Declosmenil F, Farhat A, et al. La prostaglandine D2 - Nouveaux rôles dans la gonade embryonnaire et pathologique . Med Sci (Paris). 2008; ; 24 : :177.–183.
11.
Urade Y, Fujimoto N, Hayaishi O. Purification and characterization of rat brain prostaglandin D synthetase . J Biol Chem. 1985; ; 260 : :12410.–12415.
12.
Kanaoka Y, Fujimori K, Kikuno R, et al. Structure and chromosomal localization of human and mouse genes for hematopoietic prostaglandin D synthase. Conservation of the ancestral genomic structure of sigma-class glutathione S-transferase . Eur J Biochem. 2000; ; 267 : :3315.–3322.
13.
Hokari R, Nagata N, Kurihara C, et al. Increased expression and cellular localization of lipocalin-type prostaglandin D synthase in Helicobacter pylori-induced gastritis . J Pathol. 2009; ; 219 : :417.–426.
14.
Park JM, Kanaoka Y, Eguchi N, et al. Hematopoietic prostaglandin D synthase suppresses intestinal adenomas in ApcMin/+ mice . Cancer Res. 2007; ; 67 : :881.–889.
15.
Bach-Ngohou K, Mahe MM, Aubert P, et al. Enteric glia modulate epithelial cell proliferation and differentiation through 15-deoxy-12, 14-prostaglandin J2 . J Physiol. 2010; ; 588 : :2533.–2544.
16.
Boie Y, Sawyer N, Slipetz DM, et al. Molecular cloning and characterization of the human prostanoid DP receptor . J Biol Chem. 1995; ; 270 : :18910.–18916.
17.
Hammad H, Kool M, Soullie T, et al. Activation of the D prostanoid 1 receptor suppresses asthma by modulation of lung dendritic cell function and induction of regulatory T cells . J Exp Med. 2007; ; 204 : :357.–367.
18.
Rajakariar R, Hilliard M, Lawrence T, et al. Hematopoietic prostaglandin D2 synthase controls the onset and resolution of acute inflammation through PGD2 and 15-deoxyDelta12 14 PGJ2 . Proc Natl Acad Sci USA. 2007; ; 104 : :20979.–20984.
19.
Ishii M, Asano K, Namkoong H, et al. CRTH2 is a critical regulator of neutrophil migration and resistance to polymicrobial sepsis . J Immunol. 2012; ; 188 : :5655.–5664.
20.
Satoh T, Moroi R, Aritake K, et al. Prostaglandin D2 plays an essential role in chronic allergic inflammation of the skin via CRTH2 receptor . J Immunol. 2006; ; 177 : :2621.–2629.
21.
Ricote M, Li AC, Willson TM, et al. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation . Nature. 1998; ; 391 : :79.–82.
22.
Zamuner SR, Warrier N, Buret AG, et al. Cyclooxygenase 2 mediates post-inflammatory colonic secretory and barrier dysfunction . Gut. 2003; ; 52 : :1714.–1720.
23.
Sturm EM, Radnai B, Jandl K, et al. Opposing roles of prostaglandin D2 receptors in ulcerative colitis . J Immunol. 2014; ; 193 : :827.–839.
24.
Hawcroft G, Gardner SH, Hull MA. Expression of prostaglandin D2 receptors DP1 and DP2 by human colorectal cancer cells . Cancer Lett. 2004; ; 210 : :81.–84.
25.
Jiang C, Ting AT, Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines . Nature. 1998; ; 391 : :82.–86.
26.
Peyrin-Biroulet L, Beisner J, Wang G, et al. Peroxisome proliferator-activated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon . Proc Natl Acad Sci USA. 2010; ; 107 : :8772.–8777.
27.
Castrillo A, Diaz-Guerra MJ, Hortelano S, et al. Inhibition of IkappaB kinase and IkappaB phosphorylation by 15-deoxy-Delta(12, 14)-prostaglandin J(2) in activated murine macrophages . Mol Cell Biol. 2000; ; 20 : :1692.–1698.
28.
Hansson GC. Role of mucus layers in gut infection and inflammation . Curr Opin Microbiol. 2012; ; 15 : :57.–62.
29.
Dubuquoy L, Jansson EA, Deeb S, et al. Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis . Gastroenterology. 2003; ; 124 : :1265.–1276.
30.
Choi YH, Lee SN, Aoyagi H, et al. The extracellular signal-regulated kinase mitogen-activated protein kinase/ribosomal S6 protein kinase 1 cascade phosphorylates cAMP response element-binding protein to induce MUC5B gene expression via D-prostanoid receptor signaling . J Biol Chem. 2011; ; 286 : :34199.–34214.
31.
Wright DH, Ford-Hutchinson AW, Chadee K, Metters KM. The human prostanoid DP receptor stimulates mucin secretion in LS174T cells . Br J Pharmacol. 2000; ; 131 : :1537.–1545.
32.
Velcich A, Yang W, Heyer J, et al. Colorectal cancer in mice genetically deficient in the mucin Muc2 . Science. 2002; ; 295 : :1726.–1729.
33.
Buisine MP, Desreumaux P, Leteurtre E, et al. Mucin gene expression in intestinal epithelial cells in Crohn’s disease . Gut. 2001; ; 49 : :544.–551.
34.
Zouiten-Mekki L, Serghini M, Fekih M, et al. Rôle de la cellule épithéliale dans l’homéostasie intestinale et les maladies inflammatoires chroniques de l’intestin . Med Sci (Paris). 2013; ; 29 : :1145.–1150.
35.
Neunlist M, Van Landeghem L, Bourreille A, Savidge T. Neuro-glial crosstalk in inflammatory bowel disease . J Intern Med. 2008; ; 263 : :577.–583.
36.
Savidge TC, Newman P, Pothoulakis C, et al. Enteric glia regulate intestinal barrier function and inflammation via release of S-nitrosoglutathione . Gastroenterology. 2007; ; 132 : :1344.–1358.
37.
Neunlist M, Van Landeghem L, Mahe MM, et al. The digestive neuronal-glial-epithelial unit: a new actor in gut health and disease . Nat Rev Gastroenterol Hepatol. 2013; ; 10 : :90.–100.
38.
Neunlist M, Toumi F, Oreschkova T, et al. Human ENS regulates the intestinal epithelial barrier permeability and a tight junction-associated protein ZO-1 via VIPergic pathways . Am J Physiol Gastrointest Liver Physiol. 2003; ; 285 : :G1028.–G1036.
39.
Neunlist M, Aubert P, Bonnaud S, et al. Enteric glia inhibit intestinal epithelial cell proliferation partly through a TGF-beta1-dependent pathway . Am J Physiol Gastrointest Liver Physiol. 2007; ; 292 : :G231.–G241.
40.
Villanacci V, Bassotti G, Nascimbeni R, et al. Enteric nervous system abnormalities in inflammatory bowel diseases . Neurogastroenterol Motil. 2008; ; 20 : :1009.–1016.
41.
Barajon I, Serrao G, Arnaboldi F, et al. Toll-like receptors 3, 4, and 7 are expressed in the enteric nervous system and dorsal root ganglia . J Histochem Cytochem. 2009; ; 57 : :1013.–1023.
42.
Ruhl A. Glial cells in the gut . Neurogastroenterol Motil. 2005; ; 17 : :777.–790.
43.
Mosnier JF, Jarry A, Camdessanche JP, Antoine JC, Laboisse CL. In situ evidence of involvement of Schwann cells in ulcerative colitis: autocrine and paracrine signaling by A disintegrin and metalloprotease-17-mediated tumor necrosis factor alpha production . Hum Pathol. 2009; ; 40 : :1159.–1167.